New York A 5229: Establishes a blood clot and pulmonary embolism policy workgroup

Bill Text

Bill Search and Legislative Information | New York State Assembly 

• 

• 

• 

• 

• 

• 

• 

• 

 Skip to main content 

 New York State Assembly

 Speaker Carl E. Heastie

 --> 
 --> 

 --> 

• 
 Assembly Members 

• 
 Legislative Info 

• 
 Public Hearings 

• 
 Speaker's Press 

• 
 Assembly Reports 

• 
 Committees & More 

• Bill Search Home
• Laws
• Legislative Calendar
• Public Hearing Schedule
• Assembly Calendars
• Assembly Committee Agenda 

 Javascript must be enabled to properly view this page. 

 Bill No.: 

• Summary 
• Actions 
• Committee&nbspVotes 
• Floor&nbspVotes 
• Memo 
• Text 
• LFIN 
• Chamber&nbspVideo/Transcript 
A05229 Summary:

BILL NOA05229 

&nbsp

SAME ASSAME AS S02400

&nbsp

SPONSORSolages

&nbsp

COSPNSR

&nbsp

MLTSPNSR

&nbsp

Amd §206, Pub Health L

&nbsp

Directs the commissioner of health to establish a blood clot and pulmonary embolism policy workgroup.

Go to top A05229 Actions:

BILL NOA05229 

&nbsp

02/12/2025referred to health

01/07/2026referred to health

Go to topA05229 Committee&nbspVotes:

Go to topA05229 Floor&nbspVotes:

There are no Assembly votes for this bill in this legislative session.

Go to topA05229 Text:

 STATE OF NEW YORK
 ________________________________________________________________________

 5229

 2025-2026 Regular Sessions

 IN ASSEMBLY

 February 12, 2025
 ___________

 Introduced by M. of A. SOLAGES -- read once and referred to the Commit-
 tee on Health

 AN ACT to amend the public health law, in relation to establishing a
 blood clot and pulmonary embolism policy workgroup; and providing for
 the repeal of such provisions upon expiration thereof

 The People of the State of New York, represented in Senate and Assem-
 bly, do enact as follows:

 1 Section 1. Section 206 of the public health law is amended by adding a
 2 new subdivision 32 to read as follows:
 3 32. (a) The commissioner shall establish a blood clot and pulmonary
 4 embolism policy workgroup. The workgroup shall be composed of health
 5 care providers, patients who have experienced blood clots, family
 6 members of patients who have died from blood clots, advocates, and other
 7 interested parties and associations. The governor, the temporary presi-
 8 dent of the senate and the speaker of the assembly shall each appoint
 9 two members to the workgroup. The commissioner shall appoint the chair
 10 of the workgroup.
 11 (b) Members of the workgroup shall receive no compensation for their
 12 services, but may be paid their actual and necessary expenses incurred
 13 in serving the workgroup.
 14 (c) It shall be the duty of the workgroup to study and issue recommen-
 15 dations pertaining to the incidence and treatment of blood clots and
 16 pulmonary embolisms within the state. The workgroup shall:
 17 (i) Identify the aggregate number of people who experience blood clots
 18 and pulmonary embolisms each year in this state.
 19 (ii) Identify how data is collected regarding blood clots, pulmonary
 20 embolisms, and adverse health outcomes associated with these conditions.
 21 (iii) Identify how blood clots and pulmonary embolisms impact the
 22 lives of people in this state.
 23 (iv) Identify the standards of care for blood clot surveillance,
 24 detection, and treatment.

 EXPLANATION--Matter in italics (underscored) is new; matter in brackets
 [ ] is old law to be omitted.
 LBD06475-01-5

 A. 5229 2

 1 (v) Identify emerging treatments, therapies, and research relating to
 2 blood clots.
 3 (vi) Develop a risk surveillance system to help health care providers
 4 identify patients who may be at a higher risk of forming blood clots and
 5 pulmonary embolisms.
 6 (vii) Develop policy recommendations to help improve patient awareness
 7 of blood clot risks.
 8 (viii) Develop policy recommendations to help improve surveillance and
 9 detection of patients who may be at a higher risk of forming blood clots
 10 in licensed health care facilities, including hospitals, nursing homes,
 11 assisted living facilities, residential treatment facilities, and ambu-
 12 latory surgical centers.
 13 (ix) Develop policy recommendations relating to guidelines used that
 14 affect the standard of care for patients at risk of forming blood clots.
 15 (x) Develop policy recommendations relating to providing patients and
 16 their families with written notice of increased risks of forming blood
 17 clots.
 18 (d) The chair is authorized to create subcommittees to help with
 19 research, scheduling speakers on important subjects, and drafting a
 20 workgroup report and policy recommendations.
 21 (e) No later than one year after the effective date of this subdivi-
 22 sion, the workgroup shall submit their recommendations in the form of
 23 a written report to the commissioner, the speaker of the assembly, the
 24 temporary president of the senate, the minority leader of the assembly
 25 and the minority leader of the senate.
 26 (f) Upon receipt of the workgroup's report, the commissione